BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19128509)

  • 1. Mutation analysis of the Gadd45 gene at exon 4 in atypical fibroxanthoma.
    Sakamoto A; Akieda S; Oda Y; Iwamoto Y; Tsuneyoshi M
    BMC Dermatol; 2009 Jan; 9():1. PubMed ID: 19128509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
    Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
    Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin.
    Rizzardi C; Angiero F; Melato M
    Anticancer Res; 2003; 23(2C):1847-51. PubMed ID: 12820468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical fibroxanthoma versus benign and malignant fibrous histiocytoma. A comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53 immunostaining.
    Oshiro Y; Fukuda T; Tsuneyoshi M
    Cancer; 1995 Mar; 75(5):1128-34. PubMed ID: 7850711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD117 immunoreactivity in atypical fibroxanthoma.
    Mathew RA; Schlauder SM; Calder KB; Morgan MB
    Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultraviolet-induced p53 mutations in atypical fibroxanthoma.
    Dei Tos AP; Maestro R; Doglioni C; Gasparotto D; Boiocchi M; Laurino L; Fletcher CD
    Am J Pathol; 1994 Jul; 145(1):11-7. PubMed ID: 8030743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Itakura E; Oshiro Y; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2001 Nov; 32(11):1225-31. PubMed ID: 11727262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical fibroxanthoma: DNA ploidy analysis of 14 cases with possible histogenetic implications.
    Worrell JT; Ansari MQ; Ansari SJ; Cockerell CJ
    J Cutan Pathol; 1993 Jun; 20(3):211-5. PubMed ID: 8396160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the UV-induced molecule, Gadd45, in atypical fibroxanthoma.
    Sakamoto A; Oda Y; Tsuneyoshi M; Iwamoto Y
    Histopathology; 2007 Jun; 50(7):939-41. PubMed ID: 17543084
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procollagen 1 expression in atypical fibroxanthoma and other tumors.
    Jensen K; Wilkinson B; Wines N; Kossard S
    J Cutan Pathol; 2004 Jan; 31(1):57-61. PubMed ID: 14675286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical fibroxanthoma with keloidal collagen.
    Fussell JN; Cooke ER; Florentino F; Sheehan DJ
    Am J Dermatopathol; 2010 Oct; 32(7):713-5. PubMed ID: 20700041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical fibroxanthoma with lymphomatoid reaction.
    Zheng R; Ma L; Bichakjian CK; Lowe L; Fullen DR
    J Cutan Pathol; 2011 Jan; 38(1):8-13. PubMed ID: 21039743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical fibrous histiocytoma and atypical fibroxanthoma: presentation of two cases.
    Kram A; StaƄczyk J; Woyke S
    Pol J Pathol; 2003; 54(4):267-71. PubMed ID: 14998296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aneuploidy in atypical fibroxanthoma: DNA content quantification of 10 cases by image analysis.
    Michie BA; Reid RP; Fallowfield ME
    J Cutan Pathol; 1994 Oct; 21(5):404-7. PubMed ID: 7868751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin.
    Lee CS; Chou ST
    Pathology; 1998 Aug; 30(3):272-5. PubMed ID: 9770192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual presentation of atypical fibroxanthoma.
    Vandergriff TW; Reed JA; Orengo IF
    Dermatol Online J; 2008 Jan; 14(1):6. PubMed ID: 18319023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma.
    Mihic-Probst D; Zhao J; Saremaslani P; Baer A; Oehlschlegel C; Paredes B; Komminoth P; Heitz PU
    Anticancer Res; 2004; 24(1):19-26. PubMed ID: 15015571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.